ICMR detects two cases of HMPV in Karnataka through routine surveillance
ICMR will continue to track trends in HMPV circulation throughout the year
ICMR will continue to track trends in HMPV circulation throughout the year
Merck has also decided to end the favezelimab clinical development program
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Subscribe To Our Newsletter & Stay Updated